#200 COVID-19 with Paul Sax MD - Transmission, quarantine, PPE, diagnosis and management

Published: March 22, 2020, 7 p.m.

Practical tips and discussion of what we do and don\u2019t know about COVID-19 transmission, testing, NSAIDs, ACE inhibitors, quarantine, treatment, personal protective equipment (PPE) and more with Paul Sax MD, @paulsaxMD (Brigham and Women\u2019s Hospital/Harvard Medical School). This episode is sure to go viral! Show Notes | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com

\n\n
\n\n\nCredits\n\n
    \n
  • Written and Produced by: Sarah Phoebe Roberts MPH; Chris Chiu MD; Beth Garbitelli; Hannah Abrams; Rahul Ganatra MD, MPH; Matthew Watto MD, FACP
    \n\n
  • \n
  • Cover Art and Infographic by: Beth Garbitelli
    \n\n
  • \n
  • Hosts: Rahul Ganatra MD, MPH; Matthew Watto MD, FACP; Paul Williams MD, FACP
    \n\n
  • \n
  • Editor: Matthew Watto MD (written materials); Clair Morgan of nodderly.com
    \n\n
    \n
  • \n
  • Guest: Paul Sax MD
    \n\n
  • \n
\n\n
\n\n\nSponsor: Cayuga\n\n
\n\n\n
\n\n\nTime Stamps\n\n
    \n
  • 00:00 Intro
    \n\n
  • \n
  • \n04:12 SARS-CoV-2/COVID-19 vs. SARS, MERS, and influenza
    \n\n
  • \n
  • \n07:00 Rahul highlights areas of caution interpreting COVID cases studies
    \n\n
  • \n
  • 12:35 Sponsor
    \n\n
  • \n
  • \n13:20 Case of cold symptoms; Wearing masks in public; Advice on self quarantine with mild symptoms
    \n\n
  • \n
  • \n18:05 Patient with mild symptoms and COVID exposure; Duration of quarantine and PCR positivity
    \n\n
  • \n
  • \n21:15 Who merits testing for COVID-19
    \n\n
  • \n
  • \n23:19 Case of confirmed COVID with mild symptoms; Instructions to patient and family about quarantine
    \n\n
    \n
  • \n
  • \n25:50 COVID-19 testing characteristics (sensitivity, false negatives); Does co-infection occur?; Advice on when to send patient to a hospital
    \n\n
  • \n
  • \n30:10 ACEIs, ARBs, NSAIDS; Is reinfection possible?
    \n\n
    \n
  • \n
  • \n32:20 Pharmacotherapy: Hydroxychloroquine, Remdesivir, Tocilizumab; Definition of the \u201chigh risk\u201d patient; COVID-19 vaccine
    \n\n
    \n
  • \n
  • \n36:50 Case of healthcare worker (HCW) with COVID exposure; How long can COVID live on surfaces?
    \n\n
    \n
  • \n
  • \n40:20 Do exposed HCWs without symptoms require quarantine?
    \n\n
  • \n
  • \n41:30 Personal Protective equipment (PPE)
    \n\n
    \n
  • \n
  • \n45:00 COVID-19 in pregnancy
    \n\n
  • \n
  • \n47:30 COVID-19 and vulnerable patient populations (patients who are immigrants, homeless, incarcerated, etc.)
    \n\n
  • \n
  • \n50:45 Where should you get your COVID-19 information?
  • \n
  • \n52:30 Closing remarks and outro
  • \n